AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
MetLife (MET) stock has underperformed the financial sector, dipping 13.9% from its 52-week high and 6.8% YTD. The company reported strong Q3 2025 results, including net income of $818 million and adjusted EPS up 21%. Despite this, analysts remain moderately optimistic with a consensus rating of "Moderate Buy" and a mean price target of $93.38, a premium of 22.4% to current levels.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet